trioar Venture Capital
1 known investors
Trioar is a platform company developing next-generation antibody-based technologies to improve the efficacy and therapeutic index of antibody-based therapeutics, including enhanced ADC (antibody-drug conjugate) options. The company focuses on immuno-oncology and cell-targeting therapies for patients with tumors.
BiotechMedical Devices